loading
Galectin Therapeutics Inc stock is traded at $4.10, with a volume of 253.67K. It is up +5.67% in the last 24 hours and up +43.36% over the past month. Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
See More
Previous Close:
$3.88
Open:
$3.86
24h Volume:
253.67K
Relative Volume:
0.41
Market Cap:
$262.65M
Revenue:
-
Net Income/Loss:
$-45.08M
P/E Ratio:
-5.6164
EPS:
-0.73
Net Cash Flow:
$-33.68M
1W Performance:
+14.85%
1M Performance:
+43.36%
6M Performance:
+175.17%
1Y Performance:
+77.49%
1-Day Range:
Value
$3.86
$4.1399
1-Week Range:
Value
$3.50
$4.1994
52-Week Range:
Value
$0.726
$4.41

Galectin Therapeutics Inc Stock (GALT) Company Profile

Name
Name
Galectin Therapeutics Inc
Name
Phone
678-620-3186
Name
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Name
Employee
15
Name
Twitter
@galectingalt
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
GALT's Discussions on Twitter

Compare GALT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GALT
Galectin Therapeutics Inc
4.10 249.84M 0 -45.08M -33.68M -0.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-17-25 Resumed H.C. Wainwright Buy
Aug-13-20 Reiterated H.C. Wainwright Buy
Feb-13-19 Initiated B. Riley FBR Buy
Dec-07-17 Reiterated H.C. Wainwright Buy
Nov-28-17 Reiterated H.C. Wainwright Buy
Oct-19-17 Initiated ROTH Capital Buy
Mar-30-17 Upgrade H.C. Wainwright Neutral → Buy
Oct-03-16 Downgrade FBR & Co. Outperform → Mkt Perform
Sep-29-16 Downgrade H.C. Wainwright Buy → Neutral
Sep-28-16 Downgrade ROTH Capital Buy → Sell
Mar-28-16 Resumed H.C. Wainwright Buy
Sep-21-15 Initiated H.C. Wainwright Buy
Aug-01-14 Downgrade Aegis Capital Buy → Hold
Jul-30-14 Reiterated MLV & Co Buy
Jul-29-14 Reiterated MLV & Co Buy
Apr-02-14 Reiterated MLV & Co Buy
Feb-10-14 Reiterated Aegis Capital Buy
Jan-09-14 Reiterated Aegis Capital Buy
Dec-03-13 Initiated MLV & Co Buy
Aug-19-13 Reiterated Aegis Capital Buy
View All

Galectin Therapeutics Inc Stock (GALT) Latest News

pulisher
Aug 20, 2025

What’s next for Galectin Therapeutics Inc. stock priceEarnings Overview Summary & Weekly Top Gainers Trade List - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Will Galectin Therapeutics Inc. benefit from macro trendsJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Galectin Therapeutics Inc. Included in Top Momentum ScanJuly 2025 Drop Watch & Low Drawdown Investment Strategies - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can Galectin Therapeutics Inc. recover in the next quarterTrade Signal Summary & Intraday High Probability Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Galectin Therapeutics (NASDAQ:GALT) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Comparing Galectin Therapeutics Inc. in custom built stock radarsJuly 2025 Setups & High Accuracy Investment Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Will Galectin Therapeutics Inc. stock recover after recent dropMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Galectin Therapeutics Inc. trending in predictive chart models2025 Technical Patterns & Weekly Momentum Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Galectin Therapeutics (NASDAQ:GALT) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Will Galectin Therapeutics Inc. stock go up soonPortfolio Return Report & Technical Entry and Exit Tips - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Galectin Therapeutics (NASDAQ:GALT) Earns Buy Rating from HC Wainwright - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Galectin Therapeutics : Corporate Presentation, August 2025 - MarketScreener

Aug 19, 2025
pulisher
Aug 19, 2025

Is Galectin Therapeutics Inc. a candidate for recovery play2025 Pullback Review & Expert Curated Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Galectin Therapeutics Inc. stock retracement – recovery analysisQuarterly Risk Review & Technical Entry and Exit Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How Galectin Therapeutics Inc. stock performs during market volatilityTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Technical analysis overview for Galectin Therapeutics Inc. stockJuly 2025 Intraday Action & Growth Oriented Trade Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Galectin Therapeutics Inc. stock volume spike explained2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

HC Wainwright Has Optimistic Outlook of GALT Q3 Earnings - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Quantitative breakdown of Galectin Therapeutics Inc. recent moveMarket Volume Report & Accurate Intraday Trade Tips - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Price momentum metrics for Galectin Therapeutics Inc. explainedTreasury Yields & Fast Gaining Stock Reports - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

HC Wainwright Brokers Increase Earnings Estimates for GALT - Defense World

Aug 18, 2025
pulisher
Aug 17, 2025

What data driven models say about Galectin Therapeutics Inc.’s futureQuarterly Trade Report & Precise Buy Zone Tips - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Backtesting results for Galectin Therapeutics Inc. trading strategies2025 Key Highlights & Technical Pattern Alert System - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is it time to cut losses on Galectin Therapeutics Inc.Market Growth Summary & Community Consensus Trade Signals - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What recovery options are there for Galectin Therapeutics Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Galectin Therapeutics Reports Reduced Losses in Q2 2025 - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

Live market analysis of Galectin Therapeutics Inc.Gap Up & Safe Entry Trade Signal Reports - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Signal strength of Galectin Therapeutics Inc. stock in tech scannersJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Galectin Therapeutics Inc. a turnaround story2025 Biggest Moves & Community Verified Trade Alerts - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Does Galectin Therapeutics Inc. qualify in momentum factor screeningWeekly Market Report & Safe Entry Point Identification - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Does Galectin Therapeutics Inc. show high probability of reboundEarnings Risk Report & Consistent Growth Equity Picks - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Top Risks to Consider Before Buying Galectin Therapeutics Inc. StockJuly 2025 Momentum & AI Enhanced Execution Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Earnings visualization tools for Galectin Therapeutics Inc.Weekly Trend Report & Fast Entry High Yield Tips - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

What makes Galectin Therapeutics Inc. stock price move sharply2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Combining price and volume data for Galectin Therapeutics Inc.Trade Volume Report & Capital Protection Trade Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Predicting Galectin Therapeutics Inc. trend using moving averagesJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

why galectin therapeutics inc. stock attracts strong analyst attentionQuarterly Trade Summary & Community Consensus Trade Alerts - Newser

Aug 15, 2025

Galectin Therapeutics Inc Stock (GALT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Galectin Therapeutics Inc Stock (GALT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
FREEMAN KEVIN D
Director
Jul 17 '25
Buy
2.90
5,000
14,495
49,769
CZIRR JAMES C
10% Owner
Jun 06 '25
Option Exercise
2.16
323,125
699,344
1,045,541
Shlevin Harold H.
Director
Dec 30 '24
Buy
1.16
6,500
7,540
15,206
Jamil Khurram
Chief Medical Officer
Dec 23 '24
Option Exercise
0.00
40,000
0
40,000
Jamil Khurram
Chief Medical Officer
Dec 23 '24
Sale
0.88
13,654
12,044
26,346
LEWIS JOEL
President and CEO
Dec 23 '24
Option Exercise
0.00
56,000
0
953,012
LEWIS JOEL
President and CEO
Dec 23 '24
Sale
0.89
56,000
49,610
897,012
CALLICUTT JACK W
Chief Financial Officer
Dec 23 '24
Option Exercise
0.00
40,000
0
47,614
CALLICUTT JACK W
Chief Financial Officer
Dec 23 '24
Sale
0.89
40,000
35,492
7,614
Zordani Richard A. Jr.
Director
Dec 24 '24
Buy
0.82
10,000
8,164
42,083
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):